Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients with HIV-1 Infection: The Phase 2 DURVAST Study

by biblioteca on 4 de maig de 2020 with No hi ha comentaris

Gonzalez-Cao, M., Morán, T., Dalmau, J., Garcia-Corbacho, J., Bracht, J. W. P., Bernabe, R., Blanco, J…, Clotet, B., … Rosell, R. (2020). Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients with HIV-1 Infection: The Phase 2 DURVAST Study. JAMA Oncology. doi: 10.1001/jamaoncol.2020.0465